These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10505549)

  • 41. [Micrometastasis of bone marrow as a prognostic factor of breast cancers].
    Takeyama H; Inoue H; Yamazaki Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():460-5. PubMed ID: 11026034
    [No Abstract]   [Full Text] [Related]  

  • 42. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging.
    Bauer KD; de la Torre-Bueno J; Diel IJ; Hawes D; Decker WJ; Priddy C; Bossy B; Ludmann S; Yamamoto K; Masih AS; Espinoza FP; Harrington DS
    Clin Cancer Res; 2000 Sep; 6(9):3552-9. PubMed ID: 10999743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of minimal bone marrow infiltration in patients with localized and metastatic Ewing sarcoma using RT-PCR.
    Sumerauer D; Vícha A; Kucerová H; Kodet R; Housková J; Bedrnícek J; Eckschlager T
    Folia Biol (Praha); 2001; 47(6):206-10. PubMed ID: 11768778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A seminested RT-PCR assay for HER2/neu: initial validation of a new method for the detection of disseminated breast cancer cells.
    Wasserman L; Dreilinger A; Easter D; Wallace A
    Mol Diagn; 1999 Mar; 4(1):21-8. PubMed ID: 10229771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-specifically labelled cells that simulate bone marrow metastases in patients with non-metastatic breast cancer.
    Lagrange M; Ferrero JM; Lagrange JL; Machiavello JC; Monticelli J; Bayle C; Creisson A; Namer M; Thyss A; Bourcier C; Gioanni J; Schneider M
    J Clin Pathol; 1997 Mar; 50(3):206-11. PubMed ID: 9155670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
    Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
    Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19.
    Moscinski LC; Trudeau WL; Fields KK; Elfenbein GJ
    Diagn Mol Pathol; 1996 Sep; 5(3):173-80. PubMed ID: 8866230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone marrow micrometastases and gastrointestinal cancer detection and significance.
    Maguire D; O'Sullivan GC; Collins JK; Morgan J; Shanahan F
    Am J Gastroenterol; 2000 Jul; 95(7):1644-51. PubMed ID: 10925963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone marrow micrometastases in breast cancer patients.
    Simmons R; Hoda S; Osborne M
    Am J Surg; 2000 Oct; 180(4):309-12. PubMed ID: 11113442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells.
    Pantel K; Otte M
    Semin Cancer Biol; 2001 Oct; 11(5):327-37. PubMed ID: 11562175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR.
    Berois N; Varangot M; Osinaga E; Babino A; Caignault L; Musé I; Roseto A
    Anticancer Res; 1997; 17(4A):2639-46. PubMed ID: 9252694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of molecular cytokeratin 19 reverse transcriptase polymerase chain reaction (CK19 RT-PCR) and immunocytochemical detection of micrometastatic breast cancer cells in hematopoietic harvests.
    Traystman MD; Cochran GT; Hake SJ; Kuszynski CA; Mann SL; Murphy BJ; Pirruccello SJ; Zuvanich E; Sharp JG
    J Hematother; 1997 Dec; 6(6):551-61. PubMed ID: 9483190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunocytological detection of isolated tumour cells in the bone marrow of malignant melanoma patients: a new method for the detection of minimal residual disease.
    Thybusch-Bernhardt A; Klomp HJ; Maas T; Kremer B; Juhl H
    Eur J Surg Oncol; 1999 Oct; 25(5):498-502. PubMed ID: 10527598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
    Fields KK; Elfenbein GJ; Trudeau WL; Perkins JB; Janssen WE; Moscinski LC
    J Clin Oncol; 1996 Jun; 14(6):1868-76. PubMed ID: 8656255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
    Ghossein RA; Carusone L; Bhattacharya S
    In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow.
    Zhong XY; Kaul S; Eichler A; Bastert G
    Arch Gynecol Obstet; 1999 Nov; 263(1-2):2-6. PubMed ID: 10728619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview.
    Zippelius A; Pantel K
    Ann N Y Acad Sci; 2000 Apr; 906():110-23. PubMed ID: 10818606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The detection of isolated tumor cells in bone marrow comparing bright-field immunocytochemistry and multicolor immunofluorescence.
    Krag DN; Kusminsky R; Manna E; Ambaye A; Weaver DL; Harlow SP; Covelli M; Stanley MA; McCahill L; Ittleman F; Leavitt B; Krag M
    Ann Surg Oncol; 2005 Sep; 12(9):753-60. PubMed ID: 16079954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.
    Cheung NK; Kushner BH; Cheung IY; Kramer K; Canete A; Gerald W; Bonilla MA; Finn R; Yeh SJ; Larson SM
    J Clin Oncol; 1998 Sep; 16(9):3053-60. PubMed ID: 9738575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.